Literature DB >> 19845797

Auxiliary role for D-alanylated wall teichoic acid in Toll-like receptor 2-mediated survival of Staphylococcus aureus in macrophages.

Akiko Shiratsuchi1, Kaori Shimizu, Ikuko Watanabe, Yumi Hashimoto, Kenji Kurokawa, Iony M Razanajatovo, Keun H Park, Hae K Park, Bok L Lee, Kazuhisa Sekimizu, Yoshinobu Nakanishi.   

Abstract

We previously reported that Staphylococcus aureus avoids killing within macrophages by exploiting the action of Toll-like receptor 2 (TLR2), which leads to the c-Jun N-terminal kinase (JNK)-mediated inhibition of superoxide production. To search for bacterial components responsible for this event, a series of S. aureus mutants, in which the synthesis of the cell wall was interrupted, were screened for the level of JNK activation in macrophages. In addition to a mutant lacking the lipoproteins that have been suggested to act as a TLR2 ligand, two mutant strains were found to activate the phosphorylation of JNK to a lesser extent than the parental strain, and this defect was recovered by acquisition of the corresponding wild-type genes. Macrophages that had phagocytosed the mutant strains produced more superoxide than those engulfing the parental strain, and the mutant bacteria were more efficiently killed in macrophages than the parent. The genes mutated, dltA and tagO, encoded proteins involved in the synthesis of D-alanylated wall teichoic acid. Unlike a cell wall fraction rich in lipoproteins, D-alanine-bound wall teichoic acid purified from the parent strain by itself did not activate JNK phosphorylation in macrophages. These results suggest that the d-alanylated wall teichoic acid of S. aureus modulates the cell wall milieu for lipoproteins so that they effectively serve as a ligand for TLR2.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19845797      PMCID: PMC2814468          DOI: 10.1111/j.1365-2567.2009.03168.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  43 in total

1.  Colony spreading in Staphylococcus aureus.

Authors:  Chikara Kaito; Kazuhisa Sekimizu
Journal:  J Bacteriol       Date:  2006-12-28       Impact factor: 3.490

2.  Comment on "Not lipoteichoic acid but lipoproteins appear to be the dominant immunobiologically active compounds in Staphylococcus aureus".

Authors:  Sonja von Aulock; Thomas Hartung; Corinna Hermann
Journal:  J Immunol       Date:  2007-03-01       Impact factor: 5.422

Review 3.  Signalling and phagocytosis in the orchestration of host defence.

Authors:  J Magarian Blander
Journal:  Cell Microbiol       Date:  2007-02       Impact factor: 3.715

4.  TLR2-mediated survival of Staphylococcus aureus in macrophages: a novel bacterial strategy against host innate immunity.

Authors:  Ikuko Watanabe; Manami Ichiki; Akiko Shiratsuchi; Yoshinobu Nakanishi
Journal:  J Immunol       Date:  2007-04-15       Impact factor: 5.422

5.  Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy.

Authors:  Lionel Apetoh; François Ghiringhelli; Antoine Tesniere; Michel Obeid; Carla Ortiz; Alfredo Criollo; Grégoire Mignot; M Chiara Maiuri; Evelyn Ullrich; Patrick Saulnier; Huan Yang; Sebastian Amigorena; Bernard Ryffel; Franck J Barrat; Paul Saftig; Francis Levi; Rosette Lidereau; Catherine Nogues; Jean-Paul Mira; Agnès Chompret; Virginie Joulin; Françoise Clavel-Chapelon; Jean Bourhis; Fabrice André; Suzette Delaloge; Thomas Tursz; Guido Kroemer; Laurence Zitvogel
Journal:  Nat Med       Date:  2007-08-19       Impact factor: 53.440

6.  Two-component signaling in the virulence of Staphylococcus aureus: a silkworm larvae-pathogenic agent infection model of virulence.

Authors:  Kenji Kurokawa; Chikara Kaito; Kazuhisa Sekimizu
Journal:  Methods Enzymol       Date:  2007       Impact factor: 1.600

7.  Role of D-alanylation of Streptococcus gordonii lipoteichoic acid in innate and adaptive immunity.

Authors:  Karenn G Chan; Matt Mayer; Elisabeth M Davis; Scott A Halperin; Tong-Jun Lin; Song F Lee
Journal:  Infect Immun       Date:  2007-04-09       Impact factor: 3.441

Review 8.  Understanding how leading bacterial pathogens subvert innate immunity to reveal novel therapeutic targets.

Authors:  Victor Nizet
Journal:  J Allergy Clin Immunol       Date:  2007-07       Impact factor: 10.793

9.  Molecular basis of resistance to muramidase and cationic antimicrobial peptide activity of lysozyme in staphylococci.

Authors:  Silvia Herbert; Agnieszka Bera; Christiane Nerz; Dirk Kraus; Andreas Peschel; Christiane Goerke; Michael Meehl; Ambrose Cheung; Friedrich Götz
Journal:  PLoS Pathog       Date:  2007-07-27       Impact factor: 6.823

10.  Wolbachia lipoprotein stimulates innate and adaptive immunity through Toll-like receptors 2 and 6 to induce disease manifestations of filariasis.

Authors:  Joseph D Turner; R Stuart Langley; Kelly L Johnston; Katrin Gentil; Louise Ford; Bo Wu; Maia Graham; Faye Sharpley; Barton Slatko; Eric Pearlman; Mark J Taylor
Journal:  J Biol Chem       Date:  2009-05-19       Impact factor: 5.157

View more
  9 in total

1.  In vitro antimicrobial activity of wall teichoic acid biosynthesis inhibitors against Staphylococcus aureus isolates.

Authors:  Takashi Suzuki; Jonathan G Swoboda; Jennifer Campbell; Suzanne Walker; Michael S Gilmore
Journal:  Antimicrob Agents Chemother       Date:  2010-11-22       Impact factor: 5.191

2.  Glycoepitopes of staphylococcal wall teichoic acid govern complement-mediated opsonophagocytosis via human serum antibody and mannose-binding lectin.

Authors:  Kenji Kurokawa; Dong-Jun Jung; Jang-Hyun An; Katharina Fuchs; Yu-Jin Jeon; Na-Hyang Kim; Xuehua Li; Koichiro Tateishi; Ji Ae Park; Guoqing Xia; Misao Matsushita; Kazue Takahashi; Hee-Ju Park; Andreas Peschel; Bok Luel Lee
Journal:  J Biol Chem       Date:  2013-09-17       Impact factor: 5.157

3.  In Staphylococcus aureus, the Particulate State of the Cell Envelope Is Required for the Efficient Induction of Host Defense Responses.

Authors:  ByungHyun Kim; TingTing Jiang; Jun-Hyun Bae; Hye Su Yun; Seong Han Jang; Jung Hyun Kim; Jae Deog Kim; Jin-Hoe Hur; Kensuke Shibata; Kenji Kurokawa; Yunjin Jung; Andreas Peschel; Taeok Bae; Bok Luel Lee
Journal:  Infect Immun       Date:  2019-11-18       Impact factor: 3.441

4.  Surface Glycopolymers Are Crucial for In Vitro Anti-Wall Teichoic Acid IgG-Mediated Complement Activation and Opsonophagocytosis of Staphylococcus aureus.

Authors:  Jong-Ho Lee; Na-Hyang Kim; Volker Winstel; Kenji Kurokawa; Jesper Larsen; Jang-Hyun An; Adnan Khan; Min-Young Seong; Min Ja Lee; Paal Skytt Andersen; Andreas Peschel; Bok Luel Lee
Journal:  Infect Immun       Date:  2015-08-17       Impact factor: 3.441

5.  Human SAP is a novel peptidoglycan recognition protein that induces complement-independent phagocytosis of Staphylococcus aureus.

Authors:  Jang-Hyun An; Kenji Kurokawa; Dong-Jun Jung; Min-Jung Kim; Chan-Hee Kim; Yukari Fujimoto; Koichi Fukase; K Mark Coggeshall; Bok Luel Lee
Journal:  J Immunol       Date:  2013-08-21       Impact factor: 5.422

Review 6.  Teichoic acid biosynthesis as an antibiotic target.

Authors:  Lincoln W Pasquina; John P Santa Maria; Suzanne Walker
Journal:  Curr Opin Microbiol       Date:  2013-07-31       Impact factor: 7.934

7.  A Streptococcus pneumoniae infection model in larvae of the wax moth Galleria mellonella.

Authors:  B A Evans; D E Rozen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-04-01       Impact factor: 3.267

8.  Lactobacillus plantarum lipoteichoic acid inhibits biofilm formation of Streptococcus mutans.

Authors:  Ki Bum Ahn; Jung Eun Baik; Ok-Jin Park; Cheol-Heui Yun; Seung Hyun Han
Journal:  PLoS One       Date:  2018-02-08       Impact factor: 3.240

9.  Host Defense and the Airway Epithelium: Frontline Responses That Protect against Bacterial Invasion and Pneumonia.

Authors:  Nicholas A Eisele; Deborah M Anderson
Journal:  J Pathog       Date:  2011-09-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.